Cargando…

Membrane connectivity estimated by digital image analysis of HER2 immunohistochemistry is concordant with visual scoring and fluorescence in situ hybridization results: algorithm evaluation on breast cancer tissue microarrays

INTRODUCTION: The human epidermal growth factor receptor 2 (HER2) is an established biomarker for management of patients with breast cancer. While conventional testing of HER2 protein expression is based on semi-quantitative visual scoring of the immunohistochemistry (IHC) result, efforts to reduce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Laurinaviciene, Aida, Dasevicius, Darius, Ostapenko, Valerijus, Jarmalaite, Sonata, Lazutka, Juozas, Laurinavicius, Arvydas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Methodology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3191356/ https://www.ncbi.nlm.nih.gov/pubmed/21943197 http://dx.doi.org/10.1186/1746-1596-6-87

Ejemplares similares

Immunohistochemistry profiles of breast ductal carcinoma: factor analysis of digital image analysis data
por: Laurinavicius, Arvydas, et al.
Publicado: (2012)

Independent Prognostic Value of Intratumoral Heterogeneity and Immune Response Features by Automated Digital Immunohistochemistry Analysis in Early Hormone Receptor-Positive Breast Carcinoma
por: Zilenaite, Dovile, et al.
Publicado: (2020)

Intratumoral Heterogeneity and Immune Response Indicators to Predict Overall Survival in a Retrospective Study of HER2-Borderline (IHC 2+) Breast Cancer Patients
por: Radziuviene, Gedmante, et al.
Publicado: (2021)

Ki67/SATB1 ratio is an independent prognostic factor of overall survival in patients with early hormone receptor-positive invasive ductal breast carcinoma
por: Laurinavicius, Arvydas, et al.
Publicado: (2015)

Automated Image Analysis of HER2 Fluorescence In Situ Hybridization to Refine Definitions of Genetic Heterogeneity in Breast Cancer Tissue
por: Radziuviene, Gedmante, et al.
Publicado: (2017)

Digital Image Analysis in Pathology: Benefits and Obligation
por: Laurinavicius, Arvydas, et al.
Publicado: (2012)

Analysis of Intrinsic Breast Cancer Subtypes: The Clinical Utility of Epigenetic Biomarkers and TP53 Mutation Status in Triple-Negative Cases
por: Sadzeviciene, Ieva, et al.
Publicado: (2022)

Digital immunohistochemistry: new horizons and practical solutions in breast cancer pathology
por: Laurinavicius, Arvydas, et al.
Publicado: (2013)

Decreased expression of MT1E is a potential biomarker of prostate cancer progression
por: Demidenko, Rita, et al.
Publicado: (2017)

Digital immunohistochemistry wizard: image analysis-assisted stereology tool to produce reference data set for calibration and quality control
por: Plancoulaine, Benoît, et al.
Publicado: (2014)

Digital immunohistochemistry platform for the staining variation monitoring based on integration of image and statistical analyses with laboratory information system
por: Laurinaviciene, Aida, et al.
Publicado: (2014)

The Emerging Role of Chromatin Remodeling Complexes in Ovarian Cancer
por: Vaicekauskaitė, Ieva, et al.
Publicado: (2022)

Impact of tissue sampling on accuracy of Ki67 immunohistochemistry evaluation in breast cancer
por: Besusparis, Justinas, et al.
Publicado: (2016)

Determination of the HER2 amplification status by in situ fluorescent hybridization and concordance with immunohistochemistry for breast cancer samples in Colombia
por: Plata, Adriana, et al.
Publicado: (2013)

A methodology to ensure and improve accuracy of Ki67 labelling index estimation by automated digital image analysis in breast cancer tissue
por: Laurinavicius, Arvydas, et al.
Publicado: (2014)

Nongenotoxic ABCB1 activator tetraphenylphosphonium can contribute to doxorubicin resistance in MX-1 breast cancer cell line
por: Kubiliute, Raimonda, et al.
Publicado: (2021)

A rapid and sensitive, multiplex, whole mount RNA fluorescence in situ hybridization and immunohistochemistry protocol
por: Huang, Tian, et al.
Publicado: (2023)

Frequent down-regulation of ABC transporter genes in prostate cancer
por: Demidenko, Rita, et al.
Publicado: (2015)

The utility of urine-circulating miRNAs for detection of prostate cancer
por: Stuopelyte, Kristina, et al.
Publicado: (2016)

Malignant phyllodes tumor of the breast with metastases to the lungs: A case report and literature review
por: Ostapenko, Edvin, et al.
Publicado: (2022)

Tumor collagen framework from bright-field histology images predicts overall survival of breast carcinoma patients
por: Morkunas, Mindaugas, et al.
Publicado: (2021)

Comparison of HER2 status by fluorescence in situ hybridisation and immunohistochemistry in gastric cancer
por: Chen, Ming, et al.
Publicado: (2014)

Promoter Methylation of PRKCB, ADAMTS12, and NAALAD2 Is Specific to Prostate Cancer and Predicts Biochemical Disease Recurrence
por: Daniunaite, Kristina, et al.
Publicado: (2021)

Quantification Accuracy of Liver Fibrosis by In Vivo Elastography and Digital Image Analysis of Liver Biopsy Histochemistry
por: Besusparis, Justinas, et al.
Publicado: (2014)

Intranuclear birefringent inclusions in paraffin sections by polychromatic polarization microscopy
por: Vitkunaite, Aiste, et al.
Publicado: (2021)

Development of automated brightfield double In Situ hybridization (BDISH) application for HER2 gene and chromosome 17 centromere (CEN 17) for breast carcinomas and an assay performance comparison to manual dual color HER2 fluorescence In Situ hybridization (FISH)
por: Nitta, Hiroaki, et al.
Publicado: (2008)

ALK Gene Rearrangements in Lung Adenocarcinomas: Concordance of Immunohistochemistry, Fluorescence In Situ Hybridization, RNA In Situ Hybridization, and RNA Next-Generation Sequencing Testing
por: Canterbury, Carleigh R., et al.
Publicado: (2021)

Immuno-Interface Score to Predict Outcome in Colorectal Cancer Independent of Microsatellite Instability Status
por: Nestarenkaite, Ausrine, et al.
Publicado: (2020)

Comparison of immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) assessment for Her-2 status in breast cancer
por: Sui, Weiguo, et al.
Publicado: (2009)

Concordance between Immunohistochemistry and Microarray Gene Expression Profiling for Estrogen Receptor, Progesterone Receptor, and HER2 Receptor Statuses in Breast Cancer Patients in Lebanon
por: Fakhri, Ghina B., et al.
Publicado: (2018)

Kappa and lambda light chain mRNA in situ hybridization compared to flow cytometry and immunohistochemistry in B cell lymphomas
por: Rimsza, Lisa M, et al.
Publicado: (2014)

High Concordance of a Closed-System, RT-qPCR Breast Cancer Assay for HER2 mRNA, Compared to Clinically Determined Immunohistochemistry, Fluorescence in situ Hybridization, and Quantitative Immunofluorescence
por: Wasserman, Brad E., et al.
Publicado: (2017)

Correlation of Immunohistochemistry and Fluorescence in Situ Hybridization for HER-2 Assessment in Breast Cancer Patients: Single Centre Experience
por: Bogdanovska-Todorovska, Magdalena, et al.
Publicado: (2018)

Comparison of Chromogenic In Situ Hybridisation with Fluorescence In Situ Hybridisation and Immunohistochemistry for the Assessment of Her-2/neu Oncogene in Archival Material of Breast Carcinoma
por: Pothos, Alexios, et al.
Publicado: (2008)

Are There More HER2 FISH in the Sea? An Institution’s Experience in Identifying HER2 Positivity Using Fluorescent In Situ Hybridization in Patients with HER2 Negative Immunohistochemistry
por: Suydam, Camille, et al.
Publicado: (2023)

Low Level of Her-2 Locus Amplification by Fluorescent In Situ Hybridization Does Not Correlate with Her-2 Protein Overexpression by Immunohistochemistry in Barrett's Esophagus
por: Rygiel, Agnieszka M., et al.
Publicado: (2010)

A new in situ hybridization and immunohistochemistry with a novel antibody to detect small T-antigen expressions of Merkel cell polyomavirus (MCPyV)
por: Matsushita, Michiko, et al.
Publicado: (2014)

High quality protein microarray using in situ protein purification
por: Kwon, Keehwan, et al.
Publicado: (2009)

Dorsal horn-enriched genes identified by DNA microarray, in situ hybridization and immunohistochemistry
por: Sun, Hong, et al.
Publicado: (2002)

Evaluation of HER-2/neu status in breast cancer specimens using immunohistochemistry (IHC) & fluorescence in-situ hybridization (FISH) assay
por: Goud, Kalal Iravathy, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_d25vnl7j43gilihtipk30amlrn